DalsnaFinance

Nano X Imaging LTD $NNOX

Health Care

Israel
Create a scorecard

Live price temporarily unavailable.

Price history
Loading chart…

Nano X Imaging LTD (NNOX) is a Health Care company. Latest news and coverage below.

IPO: August 21, 2020 · $18.00 offering · NASDAQ · View IPO details →

Nano X Imaging LTD revenue & net income history (FY2018–FY2025)

RevenueNet incomeNet margin (right axis, %)
$13.0M−$50.1M−$113.2MFY2018 net income: −$1.91M'18FY2019 net income: −$22.6M'19FY2020 net income: −$43.8M'20FY2021 revenue: $270.0KFY2021 net income: −$61.8M · Net margin −22888.1%'21FY2022 revenue: $270.0KFY2022 net income: −$113.2M · Net margin −41941.9%'22FY2023 revenue: $9.90MFY2023 net income: −$60.8M · Net margin −613.6%'23FY2024 revenue: $11.3MFY2024 net income: −$53.5M · Net margin −474.3%'24FY2025 revenue: $13.0MFY2025 net income: −$75.0M · Net margin −576.1%'25−100%−75%−50%−25%0%FY2021 net margin: −22888.1% (off the scale, which stops at −100.0%)FY2022 net margin: −41941.9% (off the scale, which stops at −100.0%)FY2023 net margin: −613.6% (off the scale, which stops at −100.0%)FY2024 net margin: −474.3% (off the scale, which stops at −100.0%)FY2025 net margin: −576.1% (off the scale, which stops at −100.0%)
Nano X Imaging LTD annual financial statements
FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue———$270.0K$270.0K$9.90M$11.3M$13.0M
Growth (year over year)————0.0%+3568.5%+13.9%+15.4%
Gross profit———−$1.51M−$6.88M−$6.59M−$10.6M−$12.8M
Gross margin———−560.0%−2548.1%−66.6%−94.0%−98.2%
Operating income−$1.90M−$22.6M−$43.9M−$61.6M−$117.7M−$62.6M−$56.7M−$78.2M
Operating margin———−22799.3%−43596.3%−631.9%−502.9%−600.8%
Net income−$1.91M−$22.6M−$43.8M−$61.8M−$113.2M−$60.8M−$53.5M−$75.0M
Net margin———−22888.1%−41941.9%−613.6%−474.3%−576.1%
EPS (diluted)−$0.09−$0.90−$1.23−$1.28−$2.17−$1.08−$0.91−$1.16
Balance sheet
Cash and equivalents$5.00K$8.07M$213.5M$66.6M$38.5M$56.4M$39.3M$49.2M
Total assets—$11.9M$236.1M$363.2M$253.9M$218.6M$210.0M$162.2M
Total liabilities—$20.6M$5.40M$71.0M$37.3M$23.1M$20.9M$22.4M
Long-term debt————$3.48M———
Shareholders' equity−$6.38M−$8.78M$230.7M$292.1M$216.7M$195.5M$189.1M$139.7M
Cash flow
Operating cash flow−$3.67M−$5.52M−$21.6M−$38.1M−$43.4M−$44.8M−$36.6M−$40.8M
Capital expenditure$73.0K$125.0K$13.9M$23.2M$7.17M$3.30M$2.77M$4.21M
Free cash flow−$3.74M−$5.65M−$35.5M−$61.2M−$50.6M−$48.1M−$39.4M−$45.0M

From Nano X Imaging LTD's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

About Nano X Imaging LTD

Headquarters
Petach Tikva, Israel From SEC filings, Oct 2026

Recent News

No recent news mentioning Nano X Imaging LTD in our feed yet.

More Health Care stocks

Browse all companies →